EQIX vs LINE
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Equinix exhibits a severe valuation disconnect, with a current price of $1076.40 dwarfing both its Graham Number ($211.38) and Intrinsic Value ($96.46). The Piotroski F-Score of 4/9 indicates only stable financial health, while a dividend payout ratio of 136.34% is fundamentally unsustainable. Despite strong market positioning in AI infrastructure, the PEG ratio of 5.00 and bearish insider activity from the CEO and CFO suggest the stock is priced for perfection in a way that current growth rates (8.1% YoY) cannot support.
Lineage, Inc. exhibits significant fundamental weakness, highlighted by a critical Piotroski F-Score of 2/9, indicating poor financial health. While the stock trades at a slight discount to book value (P/B 0.94) and has recently outperformed low earnings expectations, these are overshadowed by a 0/100 technical trend and stagnant revenue growth (-0.20% YoY). Liquidity is a concern with a current ratio of 0.80, and the negative forward P/E suggests continued profitability struggles. The high dividend yield of 6.20% appears unsustainable given the negative profit margins.
Compare Another Pair
Related Comparisons
EQIX vs LINE: Head-to-Head Comparison
This page compares Equinix, Inc. (EQIX) and Lineage, Inc. (LINE) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.